Authors' Reply to Crampe and Langabeer: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia

Mol Diagn Ther. 2015 Aug;19(4):253-4. doi: 10.1007/s40291-015-0152-5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Fusion Proteins, bcr-abl / genetics*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Pathology, Molecular / standards*

Substances

  • Fusion Proteins, bcr-abl